Back to search
Intraductal Papillary Mucinous Neoplasm of Pancreas
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Intraductal Papillary Mucinous Neoplasm of Pancreas trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Intraductal Papillary Mucinous Neoplasm of Pancreas trials you may qualify forLiver metastases (MTS) are the main cause of death for patients affected by colorectal carcinoma (CRC) and pancreatic ductal adenocarcinoma (PDAC), thus represe…
The primary objective is to construct a multimodal AI model (Cyst-AI) based on EUS images and clinical data such as imaging features(CT or MRI) and laboratory t…
This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study ai…
The Florida Pancreas Collaborative wants to partner with individuals who are known to have, or are suspected to have a pancreatic lesion, tumor, cyst, mass, can…
The purpose of this study is for researchers to find ways of detecting pancreatic ductal adenocarcinoma/PDAC early to avoid the invasive procedure of surgery. T…
Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors t…
Intraductal Papillary Mucinous Neoplasms (IPMN) are pancreatic cystic neoplasms managed through imaging-based surveillance focused on oncologic risk. However, I…
The purpose of this Study is to assist in implementing a practical, easy-to-adopt lifestyle intervention that optimizes patient outcomes and minimizes pancreati…
This research is being done to learn more about pancreatic cysts. The tests that are currently available are imperfect at determining exactly what type of pancr…